Salvage Surgery for Cervical Cancer Recurrences

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Oncology

Background:

• Cervical cancer often presents at advanced stages and is treated with chemoradiation.
• Local recurrence after chemoradiation affects 15-20% of patients.
• Radical surgical resection is the primary curative option for recurrent cervical cancer.

Purpose of the Study:

• To evaluate the morbidity and survival outcomes of radical hysterectomy and pelvic exenteration for recurrent cervical cancer.
• To compare the effectiveness of two surgical approaches for managing cervical cancer recurrence.

Main Methods:

• Retrospective review of medical records for patients undergoing surgery for cervical cancer recurrence (January 2010 - December 2014).
• Surgical procedures included pelvic exenteration (n=13) and radical hysterectomy (n=7).
• Postoperative morbidity and survival outcomes were analyzed using Kaplan-Meier methods.

Main Results:

• Pelvic exenteration had higher operating times, blood transfusion needs, and hospital stays compared to radical hysterectomy.
• Postoperative complications occurred in 76.9% of pelvic exenteration patients (e.g., urinary tract infections, renal insufficiency, fistulae).
• Median survival was 28 months for pelvic exenteration versus 14 months for radical hysterectomy; 3-year overall survival was 43%.

Conclusions:

• Radical surgical resection is a feasible treatment for recurrent cervical cancer, offering good survival and acceptable morbidity.
• Pelvic exenteration demonstrates superior long-term survival but is associated with significant short- and long-term complications.
• Radical hysterectomy is a viable option for select patients with limited central recurrence.